Histopathological grading of pediatric ependymoma: Reproducibility and clinical relevance in European trial cohorts

Journal of Negative Results in BioMedicine

Volumn 10, Issue 1, 2011, Pages

  Ellison, David W ^a   Kocak, Mehmet ^a   Figarella Branger, Dominique ^b   Felice, Giangaspero ^c   Catherine, Godfraind ^d   Pietsch, Torsten ^e   Frappaz, Didier ^f   Massimino, Maura ^g   Grill, Jacques ^h   Boyett, James M ^a   Grundy, Richard G ⁱ  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b TIMONE HOSPITAL   (France)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^e UNIVERSITY HOSPITAL BONN   (Germany)

^f CENTRE LÉON BÉRARD   (France)

^g NATIONAL CANCER INSTITUTE   (Italy)

^h INSTITUT GUSTAVE ROUSSY   (France)

ⁱ UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ARTICLE; CANCER SURGERY; CELL DENSITY; CHILD; EPENDYMOMA; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MITOSIS; NECROSIS; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PROGNOSIS; PROGRESSION FREE SURVIVAL; REPRODUCIBILITY; SCHOOL CHILD; BRAIN TUMOR; CLINICAL TRIAL (TOPIC); COHORT ANALYSIS; DISEASE FREE SURVIVAL; INFANT; PATHOLOGY;

TUMOR MARKER;

BRAIN NEOPLASMS; CHILD; CLINICAL TRIALS AS TOPIC; COHORT STUDIES; DISEASE-FREE SURVIVAL; EPENDYMOMA; HUMANS; INFANT; TUMOR MARKERS, BIOLOGICAL;

EID: 79957639069     PISSN: None     EISSN: 14775751     Source Type: Journal    
DOI: 10.1186/1477-5751-10-7     Document Type: Article

References (34)

1. The 2007 WHO classification of tumours of the central nervous system. DN Louis H Ohgaki OD Wiestler WK Cavenee PC Burger A Jouvet BW Scheithauer P Kleihues, Acta Neuropathol 2007 114 97 109 10.1007/s00401-007-0243-4 17618441 (Pubitemid 47103521)
2. Incidence patterns for ependymoma: a surveillance, epidemiology, and end results study. CS McGuire KL Sainani PG Fisher, J Neurosurg 2009 110 725 729 10.3171/2008.9.JNS08117 19061350
3. Ependymoma: new therapeutic approaches including radiation and chemotherapy. TE Merchant M Fouladi, J Neurooncol 2005 75 287 299 10.1007/s11060-005-6753-9 16195801 (Pubitemid 43019484)
4. Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology. J Grill MC Le Deley D Gambarelli MA Raquin D Couanet A Pierre-Kahn JL Habrand F Doz D Frappaz JC Gentet C Edan P Chastagner C Kalifa, J Clin Oncol 2001 19 1288 1296 11230470 (Pubitemid 32202532)
5. Childhood ependymoma: a systematic review of treatment options and strategies. J Grill C Pascal K Chantal, Paediatr Drugs 2003 5 533 543 10.2165/00148581-200305080-00004 12895136 (Pubitemid 37046765)
6. Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study. RG Grundy SA Wilne CL Weston K Robinson LS Lashford J Ironside T Cox WK Chong RH Campbell CC Bailey R Gattamaneni S Picton N Thorpe C Mallucci MW English JA Punt DA Walker DW Ellison D Machin, Lancet Oncol 2007 8 696 705 10.1016/S1470-2045(07)70208-5 17644039 (Pubitemid 47189085)
7. The prognostic value of histological grading of posterior fossa ependymomas in children: a Children's Oncology Group study and a review of prognostic factors. T Tihan T Zhou E Holmes, Mod Pathol 2008 21 165 177 18084249 (Pubitemid 351172168)
8. Intracranial ependymomas in children a critical review of prognostic factors and a plea for cooperation. E Bouffet G Perilongo A Canete M Massimino, Med Pediatr Oncol 1998 30 319 329 discussion 329-331 10.1002/(SICI)1096- 911X(199806)30:6<319::AID-MPO1>3.0.CO;2-H 9589080
9. Prognostic factors in intracranial ependymomas in children. D Figarella-Branger M Civatte C Bouvier-Labit J Gouvernet D Gambarelli JC Gentet G Lena M Choux JF Pellissier, J Neurosurg 2000 93 605 613 10.3171/jns.2000.93.4. 0605 11014538 (Pubitemid 32799294)
10. Intracranial ependymomas of childhood. Lack of correlation of histopathology and clinical outcome. PC Gerszten IF Pollack AJ Martinez KH Lo J Janosky AL Albright, Pathol Res Pract 1996 192 515 522 8857637 (Pubitemid 26289857)
11. Both location and age predict survival in ependymoma a SEER study. CS McGuire KL Sainani PG Fisher, Pediatr Blood Cancer 2009 52 65 69 10.1002/pbc.21806 19006249
12. Lack of histopathological correlation of malignant ependymomas with postoperative survival. GW Ross LJ Rubinstein, J Neurosurg 1989 70 31 36 10.3171/jns.1989.70.1.0031 2909684
13. Histologic prognostic factors in ependymoma. D Schiffer A Chio MT Giordana A Migheli L Palma B Pollo R Soffietti A Tribolo, Childs Nerv Syst 1991 7 177 182 1933913
14. Childhood intracranial ependymoma: twenty-year experience from a single institution. HK Shu WF Sall A Maity ZA Tochner AJ Janss JB Belasco LB Rorke-Adams PC Phillips LN Sutton MJ Fisher, Cancer 2007 110 432 441 10.1002/cncr.22782 17559078 (Pubitemid 47121905)
15. Prognostic factors in childhood ependymomas. LN Sutton J Goldwein G Perilongo B Lang L Schut L Rorke R Packer, Pediatr Neurosurg 1990 16 57 65 10.1159/000120509 2132926
16. Hyperfractionated radiotherapy and chemotherapy for childhood ependymoma: final results of the first prospective AIEOP (Associazione Italiana di Ematologia-Oncologia Pediatrica) study. M Massimino L Gandola F Giangaspero A Sandri P Valagussa G Perilongo ML Garre U Ricardi M Forni L Genitori G Scarzello F Spreafico S Barra M Mascarin B Pollo M Gardiman A Cama P Navarria M Brisigotti P Collini R Balter P Fidani M Stefanelli R Burnelli P Potepan M Podda G Sotti E Madon, Int J Radiat Oncol Biol Phys 2004 58 1336 1345 10.1016/j.ijrobp.2003.08.030 15050308 (Pubitemid 38438292)
17. Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. PC Burger SB Green, Cancer 1987 59 1617 1625 10.1002/1097-0142(19870501)59:9<1617::AID-CNCR2820590916>3.0.CO;2-X 3030531 (Pubitemid 17060106)
18. Alterations of protein 4.1 family members in ependymomas: a study of 84 cases. V Rajaram DH Gutmann SK Prasad DB Mansur A Perry, Mod Pathol 2005 18 991 997 10.1038/modpathol.3800390 15731777 (Pubitemid 41059962)
19. Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. SW Coons PC Johnson BW Scheithauer AJ Yates DK Pearl, Cancer 1997 79 1381 1393 10.1002/(SICI)1097- 0142(19970401)79:7<1381::AID-CNCR16>3.0.CO;2-W 9083161 (Pubitemid 27143246)
20. The prognostic significance of postoperative residual tumor in ependymoma. EA Healey PD Barnes WJ Kupsky RM Scott SE Sallan PM Black NJ Tarbell, Neurosurgery 1991 28 666 671 discussion 671-662 10.1227/00006123- 199105000-00005 1876244
21. Infratentorial ependymomas in childhood: prognostic factors and treatment. GB Nazar HJ Hoffman LE Becker D Jenkin RP Humphreys EB Hendrick, J Neurosurg 1990 72 408 417 10.3171/jns.1990.72.3.0408 2303876 (Pubitemid 20072964)
22. Intracranial ependymomas of childhood: long-term outcome and prognostic factors. IF Pollack PC Gerszten AJ Martinez KH Lo B Shultz AL Albright J Janosky M Deutsch, Neurosurgery 1995 37 655 666 discussion 666-657 10.1227/00006123- 199510000-00008 8559293
23. Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group. PL Robertson PM Zeltzer JM Boyett LB Rorke JC Allen JR Geyer P Stanley H Li AL Albright P McGuire-Cullen JL Finlay KR Stevens JM Milstein RJ Packer J Wisoff, J Neurosurg 1998 88 695 703 10.3171/jns.1998.88.4.0695 9525716 (Pubitemid 28145213)
24. Intracranial ependymoma: long-term results of a policy of surgery and radiotherapy. LJ Vanuytsel EM Bessell SE Ashley HJ Bloom M Brada, Int J Radiat Oncol Biol Phys 1992 23 313 319 10.1016/0360-3016(92)90747-6 1587752
25. Influence of tumor grade on time to progression after irradiation for localized ependymoma in children. TE Merchant JJ Jenkins PC Burger RA Sanford SH Sherwood D Jones-Wallace RL Heideman SJ Thompson KJ Helton LE Kun, Int J Radiat Oncol Biol Phys 2002 53 52 57 10.1016/S0360-3016(01)02801-2 12007941 (Pubitemid 34465807)
26. Ki-67 immunolabelling index is a prognostic indicator in childhood posterior fossa ependymomas. L Bennetto N Foreman B Harding R Hayward J Ironside S Love D Ellison, Neuropathol Appl Neurobiol 1998 24 434 440 10.1046/j.1365-2990.1998.00143.x 9888153 (Pubitemid 29002274)
27. Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma. L Ridley R Rahman MA Brundler D Ellison J Lowe K Robson E Prebble I Luckett RJ Gilbertson S Parkes V Rand B Coyle RG Grundy, Neuro Oncol 2008 10 675 689 10.1215/15228517-2008-036 18701711
28. Ki-67 immunolabeling index is an accurate predictor of outcome in patients with intracranial ependymoma. S Wolfsberger I Fischer R Hoftberger P Birner I Slavc K Dieckmann T Czech H Budka J Hainfellner, Am J Surg Pathol 2004 28 914 920 10.1097/00000478-200407000-00011 15223962 (Pubitemid 38856848)
29. Genetic abnormalities detected in ependymomas by comparative genomic hybridisation. M Carter J Nicholson F Ross J Crolla R Allibone V Balaji R Perry D Walker R Gilbertson DW Ellison, Br J Cancer 2002 86 929 939 10.1038/sj.bjc.6600180 11953826 (Pubitemid 34271030)
30. Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups. S Dyer E Prebble V Davison P Davies P Ramani D Ellison R Grundy, Am J Pathol 2002 161 2133 2141 10.1016/S0002-9440(10)64491-4 12466129 (Pubitemid 35434859)
31. ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease. RJ Gilbertson L Bentley R Hernan TT Junttila AJ Frank H Haapasalo M Connelly C Wetmore T Curran K Elenius DW Ellison, Clin Cancer Res 2002 8 3054 3064 12374672 (Pubitemid 35155014)
32. Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma. F Mendrzyk A Korshunov A Benner G Toedt S Pfister B Radlwimmer P Lichter, Clin Cancer Res 2006 12 2070 2079 10.1158/1078-0432.CCR-05-2363 16609018
33. Trisomy 19 ependymoma, a newly recognized genetico-histological association, including clear cell ependymoma. E Rousseau T Palm F Scaravilli MM Ruchoux D Figarella-Branger I Salmon D Ellison C Lacroix F Chapon J Mikol M Vikkula C Godfraind, Mol Cancer 2007 6 47 10.1186/1476-4598-6-47 17626628
34. Radial glia cells are candidate stem cells of ependymoma. MD Taylor H Poppleton C Fuller X Su Y Liu P Jensen S Magdaleno J Dalton C Calabrese J Board T Macdonald J Rutka A Guha A Gajjar T Curran RJ Gilbertson, Cancer Cell 2005 8 323 335 10.1016/j.ccr.2005.09.001 16226707 (Pubitemid 41443417)